{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T10:21:55Z","timestamp":1781518915212,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s40263-025-01215-2","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T04:15:00Z","timestamp":1756700100000},"page":"1173-1185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["International Trends in Opioid Prescribing by Age and Sex from 2001 to 2019: An Observational Study Using Population-Based Databases from 18 Countries and One Special Administrative Region"],"prefix":"10.1007","volume":"39","author":[{"given":"Adrienne Y. L.","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahram","family":"Bahmanyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebede","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Bushnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Carleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Hai Yan","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Furu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetla","family":"Gadzhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Garc\u00eda Poza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Gini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Giometto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harpa Lind","family":"Hj\u00f6rd\u00edsar J\u00f3nsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Kai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Karlstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward Chia-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyesung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallis C. Y.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ersilia","family":"Lucenteforte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9ric","family":"Maura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Potteg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotte","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Reutfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Roughead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena","family":"Saastamoinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsugumichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Scholle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. C. M.","family":"Schuiling-Veninga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Yao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Til","family":"St\u00fcrmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Taxis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tuccori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstie H. T. W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helga","family":"Zoega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth K. C.","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C. K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"issue":"10289","key":"1215_CR1","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1016\/S0140-6736(21)00393-7","volume":"397","author":"SP Cohen","year":"2021","unstructured":"Cohen SP, Vase L, Hooten WM. Chronic pain: an update on burden, best practices, and new advances. Lancet. 2021;397(10289):2082\u201397.","journal-title":"Lancet"},{"issue":"10128","key":"1215_CR2","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/S0140-6736(17)32513-8","volume":"391","author":"FM Knaul","year":"2018","unstructured":"Knaul FM, et al. Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2018;391(10128):1391\u2013454.","journal-title":"Lancet"},{"issue":"10159","key":"1215_CR3","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"Global Burden of Disease 2017 Disease and Injury Incidence and Prevalence Collaborators","year":"2018","unstructured":"Global Burden of Disease 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789\u2013858.","journal-title":"Lancet"},{"issue":"23","key":"1215_CR4","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1001\/jama.2018.18472","volume":"320","author":"JW Busse","year":"2018","unstructured":"Busse JW, et al. Opioids for chronic noncancer pain: a systematic review and meta-analysis. JAMA. 2018;320(23):2448\u201360.","journal-title":"JAMA"},{"issue":"2 Suppl","key":"1215_CR5","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.36076\/ppj.2008\/11\/S105","volume":"11","author":"R Benyamin","year":"2008","unstructured":"Benyamin R, et al. Opioid complications and side effects. Pain Physician. 2008;11(2 Suppl):S105\u201320.","journal-title":"Pain Physician"},{"issue":"10028","key":"1215_CR6","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/S0140-6736(16)00161-6","volume":"387","author":"S Berterame","year":"2016","unstructured":"Berterame S, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet. 2016;387(10028):1644\u201356.","journal-title":"Lancet"},{"issue":"4","key":"1215_CR7","doi-asserted-by":"publisher","first-page":"e335","DOI":"10.1016\/S2468-2667(22)00013-5","volume":"7","author":"C Ju","year":"2022","unstructured":"Ju C, et al. Global, regional, and national trends in opioid analgesic consumption from 2015 to 2019: a longitudinal study. Lancet Public Health. 2022;7(4):e335\u201346.","journal-title":"Lancet Public Health"},{"issue":"10","key":"1215_CR8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/S2215-0366(18)30293-1","volume":"5","author":"SR Raman","year":"2018","unstructured":"Raman SR, et al. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases. Lancet Psychiatry. 2018;5(10):824\u201335.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"1215_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.5603\/IMH.2017.0007","volume":"68","author":"SK Tayebati","year":"2017","unstructured":"Tayebati SK, et al. Identification of World Health Organisation ship\u2019s medicine chest contents by anatomical therapeutic chemical (ATC) classification codes. Int Marit Health. 2017;68(1):39\u201345.","journal-title":"Int Marit Health"},{"issue":"5","key":"1215_CR10","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1001\/jama.2021.11013","volume":"326","author":"A Agnoli","year":"2021","unstructured":"Agnoli A, et al. Association of dose tapering with overdose or mental health crisis among patients prescribed long-term opioids. JAMA. 2021;326(5):411\u20139.","journal-title":"JAMA"},{"issue":"6","key":"1215_CR11","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1007\/s11606-020-06402-z","volume":"36","author":"HT Neprash","year":"2021","unstructured":"Neprash HT, Gaye M, Barnett ML. Abrupt discontinuation of long-term opioid therapy among Medicare beneficiaries, 2012\u20132017. J Gen Intern Med. 2021;36(6):1576\u201383.","journal-title":"J Gen Intern Med"},{"issue":"7","key":"1215_CR12","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/add.15359","volume":"116","author":"CS Davis","year":"2021","unstructured":"Davis CS, Lieberman AJ. Laws limiting prescribing and dispensing of opioids in the United States, 1989\u20132019. Addiction. 2021;116(7):1817\u201327.","journal-title":"Addiction"},{"issue":"2","key":"1215_CR13","first-page":"208","volume":"14","author":"D Manjiani","year":"2014","unstructured":"Manjiani D, et al. Availability and utilization of opioids for pain management: global issues. Ochsner J. 2014;14(2):208\u201315.","journal-title":"Ochsner J"},{"issue":"1","key":"1215_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15360288.2019.1686098","volume":"34","author":"W Scholten","year":"2020","unstructured":"Scholten W, et al. Analyzing and benchmarking global consumption statistics for opioid analgesics 2015: inequality continues to increase. J Pain Palliat Care Pharmacother. 2020;34(1):1\u201312.","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"1","key":"1215_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/padr.12205","volume":"45","author":"S Ghislandi","year":"2019","unstructured":"Ghislandi S, Sanderson WC, Scherbov S. A simple measure of human development: the human life indicator. Popul Dev Rev. 2019;45(1):219\u201333.","journal-title":"Popul Dev Rev"},{"issue":"2","key":"1215_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.7326\/0003-4819-146-2-200701160-00006","volume":"146","author":"BA Martell","year":"2007","unstructured":"Martell BA, et al. Systematic review: opioid treatment for chronic back pain: prevalence, efficacy, and association with addiction. Ann Intern Med. 2007;146(2):116\u201327.","journal-title":"Ann Intern Med"},{"issue":"4","key":"1215_CR17","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1001\/jamainternmed.2018.6721","volume":"179","author":"J Friedman","year":"2019","unstructured":"Friedman J, et al. Assessment of racial\/ethnic and income disparities in the prescription of opioids and other controlled medications in California. JAMA Intern Med. 2019;179(4):469\u201376.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"1215_CR18","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/YCO.0000000000000337","volume":"30","author":"M Serdarevic","year":"2017","unstructured":"Serdarevic M, Striley CW, Cottler LB. Sex differences in prescription opioid use. Curr Opin Psychiatry. 2017;30(4):238\u201346.","journal-title":"Curr Opin Psychiatry"},{"issue":"Suppl 1","key":"1215_CR19","doi-asserted-by":"publisher","first-page":"32","DOI":"10.2106\/JBJS.20.00237","volume":"102","author":"KJ Templeton","year":"2020","unstructured":"Templeton KJ. Sex and gender issues in pain management. J Bone Jt Surg Am. 2020;102(Suppl 1):32\u20135.","journal-title":"J Bone Jt Surg Am"},{"issue":"5","key":"1215_CR20","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0022-3999(90)90027-2","volume":"34","author":"RH Corney","year":"1990","unstructured":"Corney RH. Sex differences in general practice attendance and help seeking for minor illness. J Psychosom Res. 1990;34(5):525\u201334.","journal-title":"J Psychosom Res"},{"issue":"10","key":"1215_CR21","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1001\/jamapediatrics.2021.1832","volume":"175","author":"MH Renny","year":"2021","unstructured":"Renny MH, et al. Temporal trends in opioid prescribing practices in children, adolescents, and younger adults in the US from 2006 to 2018. JAMA Pediatr. 2021;175(10):1043\u201352.","journal-title":"JAMA Pediatr"},{"issue":"6","key":"1215_CR22","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1460-9592.2010.03310.x","volume":"20","author":"OM Fredheim","year":"2010","unstructured":"Fredheim OM, et al. Prescriptions of opioids to children and adolescents; a study from a national prescription database in Norway. Paediatr Anaesth. 2010;20(6):537\u201344.","journal-title":"Paediatr Anaesth"},{"issue":"6","key":"1215_CR23","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/AJP.0000000000000707","volume":"35","author":"CB Groenewald","year":"2019","unstructured":"Groenewald CB. Opioid-prescribing patterns for pediatric patients in the United States. Clin J Pain. 2019;35(6):515\u201320.","journal-title":"Clin J Pain"},{"key":"1215_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.104447","volume":"148","author":"C Pisanu","year":"2019","unstructured":"Pisanu C, et al. Sex differences in the response to opioids for pain relief: a systematic review and meta-analysis. Pharmacol Res. 2019;148: 104447.","journal-title":"Pharmacol Res"},{"issue":"12","key":"1215_CR25","first-page":"e538","volume":"65","author":"M de Vries","year":"2019","unstructured":"de Vries M, et al. Comparative efficacy of opioids for older adults presenting to the emergency department with acute pain: Systematic review. Can Fam Physician. 2019;65(12):e538\u201343.","journal-title":"Can Fam Physician"},{"key":"1215_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12071951","author":"D Bugada","year":"2020","unstructured":"Bugada D, et al. Genetics and opioids: towards more appropriate prescription in cancer pain. Cancers (Basel). 2020. https:\/\/doi.org\/10.3390\/cancers12071951.","journal-title":"Cancers (Basel)"},{"issue":"12","key":"1215_CR27","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s40266-021-00893-z","volume":"38","author":"A Dufort","year":"2021","unstructured":"Dufort A, Samaan Z. Problematic opioid use among older adults: epidemiology, adverse outcomes and treatment considerations. Drugs Aging. 2021;38(12):1043\u201353.","journal-title":"Drugs Aging"},{"issue":"1","key":"1215_CR28","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12913-018-3058-1","volume":"18","author":"E Van Ganse","year":"2018","unstructured":"Van Ganse E, et al. Use of analgesics in France, following dextropropoxyphene withdrawal. BMC Health Serv Res. 2018;18(1):231.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"1215_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00228-020-03016-6","volume":"77","author":"AMS S\u00f8rensen","year":"2021","unstructured":"S\u00f8rensen AMS, et al. Use of tramadol and other analgesics following media attention and risk minimization actions from regulators: a Danish nationwide drug utilization study. Eur J Clin Pharmacol. 2021;77(4):617\u201324.","journal-title":"Eur J Clin Pharmacol"},{"key":"1215_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhealeco.2020.102344","volume":"72","author":"I Ahomaki","year":"2020","unstructured":"Ahomaki I, et al. Impact of a physician-targeted letter on opioid prescribing. J Health Econ. 2020;72: 102344.","journal-title":"J Health Econ"},{"key":"1215_CR31","unstructured":"The White House (Executive Office of the President). President\u2019s Commission on Combating Drug Addiction and the Opioid Crisis, Final report. 2017. https:\/\/www.hsdl.org\/?abstract&did=805384."},{"issue":"8","key":"1215_CR32","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.26523","volume":"5","author":"MR Larochelle","year":"2022","unstructured":"Larochelle MR, et al. Comparative effectiveness of opioid tapering or abrupt discontinuation vs no dosage change for opioid overdose or suicide for patients receiving stable long-term opioid therapy. JAMA Netw Open. 2022;5(8): e2226523.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"1215_CR33","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1056\/NEJMsa1610524","volume":"376","author":"ML Barnett","year":"2017","unstructured":"Barnett ML, Olenski AR, Jena AB. Opioid-prescribing patterns of emergency physicians and risk of long-term use. N Engl J Med. 2017;376(7):663\u201373.","journal-title":"N Engl J Med"},{"key":"1215_CR34","unstructured":"Anekar AA, Cascella M. WHO Analgesic Ladder. In StatPearls. 2022: Treasure Island (FL)."},{"issue":"9","key":"1215_CR35","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1526-4637.2012.01467.x","volume":"13","author":"BD Darnall","year":"2012","unstructured":"Darnall BD, Stacey BR, Chou R. Medical and psychological risks and consequences of long-term opioid therapy in women. Pain Med. 2012;13(9):1181\u2013211.","journal-title":"Pain Med"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-025-01215-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-025-01215-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:04:26Z","timestamp":1760173466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-025-01215-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1215"],"URL":"https:\/\/doi.org\/10.1007\/s40263-025-01215-2","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]},"assertion":[{"value":"1 August 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No funding was received by the principal investigators for the conduct of this study or preparation of the manuscript. Effort of Stephen Crystal and Sharon Cook in analyses of US Medicaid data was supported in part by National Institute on Drug Abuse grants R01 DA047347 and R01 DA057568. The funding source had no role in study design; in the collection, analysis, and interpretation of data; in the writing of the manuscript; or in the decision to submit it for publication. No funding was received to cover open access fees.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"A.H.Y.C. received a Universitas 21 collaborative research grant to support the work reported in this paper. A.H.Y.C. reports a senior research fellowship from Auckland Medical Research Foundation and was the previous Robert Irwin Postdoctoral Fellowship awardee at the time this work was conducted. A.H.Y.C. has received consultancy fees from AcademeX and UCL-Business spin-out Spoonful of Sugar Ltd. A.H.Y.C. has also received research grants from Asthma UK, the University of Auckland, Health Research Council of New Zealand, Oakley Mental Health Foundation, Chorus Ltd, World Health Organisation, A+ Trust and Hong Kong University, outside this submitted work. A.H.Y.C. is also a Board member of Asthma NZ and member of Respiratory Effectiveness Group (REG). J.H. has received consultancy fees from Enigma Solutions Ltd. (New Zealand)\u2014a clinical knowledge management and clinical expert system provider, Medsafe, the New Zealand Medicines and Medical Devices Safety Authority, Pharmaceutical Management Agency (a New Zealand crown entity), MIMS Pte Ltd (Singapore), Pall Corporation (New Zealand), and Sanofi (UK). J.H. has also received research grants from the University of Auckland, Health Research Council of New Zealand, Oakley Mental Health Foundation, National Heart Foundation (New Zealand), Health Workforce New Zealand, Tertiary Education Commission (New Zealand), A+ Trust and Hong Kong University, outside this submitted work. UH and OS are working at an independent, nonprofit research institute, the Leibniz Institute for Prevention Research and Epidemiology\u2014BIPS. Unrelated to this study, BIPS occasionally conducts studies financed by the pharmaceutical industry. These are post-authorization safety studies (PASS) requested by health authorities. The design and conduct of these studies as well as the interpretation and publication are not influenced by the pharmaceutical industry. P.G.P. reported close family member interest\u2014employee at TEVA. E.C.C.L. reports research funding outside the submitted work from Amgen, Pfizer, Sanofi, Takeda, Roche, IQVIA, the Taiwan National Science and Technology Council (ID:111-2628-B-006-007-), the Taiwan National Health Research Institutes. \u00d8K and KF report participation in regulator-mandated post-authorization safety studies (PASS) of drugs with no relation to the work reported in this paper with funds paid to the institution where they are employed (no personal fees). W.C.Y.L. reports grant from AIR@InnoHK administered by Innovation and Technology Commission, outside the submitted work. A.P. reports participation in research projects funded by Alcon, Almirall, Astellas, Astra-Zeneca, Boehringer-Ingelheim, Novo Nordisk, Servier and LEO Pharma, all regulator-mandated phase IV-studies, all with funds paid to the institution where he was employed (no personal fees) and with no relation to the work reported in this paper. Analyses of US Medicaid data were supported in part by NIDA grant 1R01 DA047347. KKCM is the recipient of the CW Maplethorpe Fellowship, reports grants from the European Union Horizon 2020, the UK National Institute of Health Research and the Hong Kong Research Grant Council, Hong Kong Innovation and Technology Commission, and reports personal fees from IQVIA, unrelated to the submitted work. I.C.K.W. reports research funding from the Hong Kong Research Grants Council, the Hong Kong Health and Medical Research Fund, the National Institute for Health Research in England, the European Commission, IQVIA, Amgen and GSK, consulting fees from IQVIA and World Health Organization, outside of the submitted work. He is a nonexecutive director of Jacobson Medical, Advance Data Analytics for Medical Science (ADAMS) Limited in Hong Kong and OCUS Innovation Limited (HK, Ireland and UK); a former director of Therakind in England and Asia Medicine Regulatory Affairs (AMERA) Services Limited in Hong Kong. Lotte Rasmussen reports participation in research projects funded by Novo Nordisk with funds paid to the institution where she was employed (no personal fees) and with no relation to the work reported in this paper. H.Z. was supported by a UNSW Scientia Program Award during the conduct of this study. A.Y.L.C., S.B., K.B., G.B., B.C., S.C., S.Cr., S.G., R.G., S.Gi., C.H., H.L.J., J.K., J.H.K., K.K., H.L., K.L., E.L., G.M., A.N., V.P., N.Q., J.R., L.S., T.S., C.S.-V., C.-Y.S., J.-Y.S., T.S., K.T., M.T., S.W., and K.H.T.W.W. declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"Each participating site followed the relevant local ethics and regulatory frameworks for study approval, namely, Australia: The External Requests Evaluation Committee (RMS0863); Canada: University of British Columbia Clinical Research Ethics Board (UW 19-762); Hong Kong: University of Hong Kong\/ Hospital Authority Hong Kong West Cluster (UW20-051); Iceland: National Bioethics Committee (VSN-20-058); Norway: Regional Ethics Committee (REK) (REK s\u00f8r-\u00f8st D, ref. 92144); New Zealand: Auckland Health Research Ethics Committee (26501); South Korea: Sungkyunkwan University Institutional Review Board (2019-05-006); Spain: CEIm-Regional de la Comunidad de Madrid (01\/20); Taiwan: Taiwan National Cheng Kung University Hospital Institutional Review Board (A-ER-107-387); the United Kingdom: Independent Scientific Advisory Committee (19_169); and the United States: University of North Carolina Institutional Review Board (19-3195) and Rutgers, The State University of New Jersey ArtSci Institutional Review Board (Pro2020002048). Ethical approval is exempted in Denmark, Finland, France,\u00a0Germany, Italy, the Netherlands, New Zealand, Sweden.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent\u00a0for participation"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent\u00a0for publication"}},{"value":"I.C.K.W., K.K.C.M.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"I.C.K.W., K.K.C.M., and A.Y.L.C. had full access to the aggregate analysis data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. I.C.K.W. and K.K.C.M. were responsible for the study concept, and I.C.K.W., K.K.C.M., and A.Y.L.C. were responsible for the study design. All authors were involved in the acquisition, statistical analysis, or interpretation of data. I.C.K.W., K.K.C.M., and A.Y.L.C. drafted the manuscript. All authors critically revised the manuscript for important intellectual content.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"The aggregate-level datasets generated or analyzed during the current study are available from the corresponding author on reasonable request subject to agreement from the site-investigators and their respective data providers.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability statement"}},{"value":"R codes and dataset adopted in this study are available on GitHub repository at .","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}